Discover 725 paid clinical trials in Olathe, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 725
Active & ResponsiveNew
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
for
Spasticity
Location: 3 recruiting locations
Sponsor: Ipsen
Sex: All
Age: 18 - 70
Code: NCT04752774
Phase1, Phase2, Recruiting
Active & ResponsiveNew
Building Healthy Eating and Self-Esteem Together for University Students
for
Eating Disorders (Excluding Anorexia Nervosa),
Location: 1 recruiting location
Sponsor: University of Kansas
Sex: All
Age: 18 - 65
Code: NCT07060534
Recruiting
Active & Responsive
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
for
Monkeypox (Mpox)
Location: 10 recruiting locations
Sponsor: Bavarian Nordic
Sex: All
Age: 18 - 49
Code: NCT07199569
Phase2, Recruiting
Active & Responsive
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
for
Chronic Migraine
Location: 32 recruiting locations
Sponsor: Merz Therapeutics GmbH
Sex: All
Age: 18+
Code: NCT07018713
Phase3, Recruiting
Active & Responsive
Fenofibrate for Prevention of DR Worsening
for
Diabetic Retinopathy
Location: 58 recruiting locations
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 18 - 70+
Code: NCT04661358
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age
for
SARS-CoV-2
Location: 26 recruiting locations
Sponsor: ModernaTX, Inc.
Sex: All
Age: 0 - 5
Code: NCT05436834
Phase3, Recruiting
Active & Responsive
The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers
for
Advanced Biliary Tract Cancer
Location: 5 recruiting locations
Sponsor: University of Kansas Medical Center
Sex: All
Age: 18+
Code: NCT04781192
Phase1, Phase2, Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: 28 recruiting locations
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06909565
Recruiting
Active & Responsive
Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)
for
Plantar Fibromatosis, Ledderhose Disease
Location: 53 recruiting locations
Sponsor: Endo Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06151197
Phase3, Recruiting
Active & Responsive
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer